Overview

Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy

Status:
Terminated
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
This study is a single-centered, double-blind, two-arm randomized study to determine if oral glutamine will reduce radiation toxicity for the subjects undergoing Breast Conserving Therapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Arkansas